Last updated on March 2019

A Phase 3 Study (PHOCUS) to determine whether the oncolytic virus immunotherapy called Pexa-Vec (JX-594) can slow the progression of advanced liver cancer (hepatocellular carcinoma or HCC).


Brief description of study

A Phase 3 Study (PHOCUS) to determine whether the oncolytic virus immunotherapy called Pexa-Vec (JX-594) can slow the progression of advanced liver cancer (hepatocellular carcinoma or HCC).

Detailed Study Description

This research study is for people with advanced liver cancer who have never received systemic medicine (affecting the entire body) for advanced liver cancer. This is a randomized, open-label Phase 3 study to determine whether treatment with vaccinia virus based immunotherapy (Pexa-Vec) followed by sorafenib can slow the progression of advanced liver cancer and improve quality of life compared to treatment with sorafenib alone.

To find out more about the study, if you are qualified and how to participate, please visit our PHOCUS trial website by clicking here.

 

 

Clinical Study Identifier: TX143550

Contact Investigators or Research Sites near you

Start Over

Research Site

Parkville, Australia
  Connect »

Research Site

Billings, MT USA
  Connect »

Research Site

Baltimore, MD USA
  Connect »

Research Site

Knoxville, TN USA
  Connect »

Research Site

St. Louis, MO USA
  Connect »

Research Site

Paterson, NJ USA
  Connect »

Research Site

Auckland, XX New Zealand
  Connect »

Research Site

Philadelphia, PA USA
  Connect »

Research Site

Gainesville, FL USA
  Connect »

Research Site

Stanford, CA USA
  Connect »

Research Site

Bucheon, XX South Korea
  Connect »

Research Site

Seoul, XX South Korea
  Connect »

Research Site

Brisbane, XX Australia
  Connect »

Research Site

Heidelberg, XX Australia
  Connect »

Research Site

Busan, XX South Korea
  Connect »

Research Site

Adelaide, XX Australia
  Connect »

Research Site

Camperdown, XX Australia
  Connect »

Research Site

Birmingham, AL USA
  Connect »

Research Site

Seongnam-si, XX South Korea
  Connect »

Research Site

Louisville, KY USA
  Connect »

Research Site

Jinju-si, XX South Korea
  Connect »

Research Site

Ansan, XX South Korea
  Connect »

Research Site

Columbus, OH USA
  Connect »

Research Site

Daegu, XX South Korea
  Connect »

Research Site

Minneapolis, MN USA
  Connect »

Research Site

Suwon, XX South Korea
  Connect »

Research Site

Morristown, NJ USA
  Connect »

Research Site

Ulsan, XX South Korea
  Connect »

Research Site

Christchurch, New Zealand
  Connect »

Research Site

Melbourne, Australia
  Connect »

Research Site

Changsha, XX China
  Connect »

Research Site

Guangzhou, XX China
  Connect »

Research Site

Shanghai, XX China
  Connect »

Research Site

Guangdong, XX China
  Connect »

Research Site

Heifei, XX China
  Connect »

Research Site

Harbin, XX China
  Connect »

Research Site

Changchun, China
  Connect »

Research Site

Dongbu-dong, South Korea
  Connect »

Research Site

Hangzhou Sh, China
  Connect »

Research Site

Heilongjiang, China
  Connect »

Research Site

Bedford Park, Australia
  Connect »

Research Site

Herston, Australia
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.